<DOC>
	<DOCNO>NCT02708511</DOCNO>
	<brief_summary>This pilot clinical trial study copper Cu 64-DOTA-B-Fab positron emission tomography ( PET ) /computed tomography ( CT ) image patient ovarian breast cancer . Cancer antigen ( CA ) 6 antigen ( substance ) find surface several type cancer cell cancer ovary breast . Diagnostic procedure , copper Cu 64-DOTA-B-Fab PET/CT , may help identify CA6 positive tumor allow doctor plan good treatment .</brief_summary>
	<brief_title>Copper Cu 64-DOTA-B-Fab PET/CT Imaging Patients With Ovarian Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine dosimetry 64Cu-DOTA B-Fab ( copper Cu 64-DOTA-B-Fab ) . SECONDARY OBJECTIVES : I . To evaluate safety 64Cu-DOTA B-Fab single administration . II . To evaluate ability 64Cu-DOTA B-Fab detect CA6-positive ovarian breast cancer lesion . III . To compare PET result immunohistochemistry ( IHC ) analysis excise tumor sample . OUTLINE : Patients receive copper Cu 64-DOTA-B-Fab intravenously ( IV ) follow PET/CT immediately injection , 60 minute , 120 minute , 24 hour . After completion study , patient follow 12 month .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Copper</mesh_term>
	<criteria>Patient â‰¥ 18 year old time drug administration Patient provide write informed consent Participant diagnose ovarian breast cancer schedule undergo surgical excision cancerous lesion ( ) Able remain still duration image procedure Participant le 18 yearold Participant pregnant breastfeeding Patients contraindication PET/CT complete PET/CT scan . Patients able comply study procedures Patients serious uncontrolled concurrent medical illness would limit compliance study requirement Eastern Cooperative Oncology Group ( ECOG ) performance status ( PS ) &gt; 2 Patients participate research protocol exclude study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>